Comparison of Cerebral Blood Flow in Regions Relevant to Cognition After Enzalutamide, Darolutamide, and Placebo in Healthy Volunteers: A Randomized Crossover Trial

BACKGROUND: Off-target central nervous system (CNS) effects are associated with androgen receptor (AR)-targeting treatments for prostate cancer. Darolutamide is a structurally distinct AR inhibitor with low blood–brain barrier penetration. OBJECTIVE: We compared cerebral blood flow (CBF) in grey mat...

Descripción completa

Detalles Bibliográficos
Autores principales: Williams, Steven C. R., Mazibuko, Ndaba, O’Daly, Owen, Zurth, Christian, Patrick, Fiona, Kappeler, Christian, Kuss, Iris, Cole, Patricia E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2023
Materias:
Original Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10191908/
https://www.ncbi.nlm.nih.gov/pubmed/37103658
http://dx.doi.org/10.1007/s11523-023-00959-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10191908/
https://www.ncbi.nlm.nih.gov/pubmed/37103658
http://dx.doi.org/10.1007/s11523-023-00959-5

Ejemplares similares